The expression of several T cell-specific and novel genes is repressed by trans-acting factors in immature T lymphoma clones by unknown
The Expression of Several T Cell-Specific and Novel
Genes Is Repressed by TransActing Factors in
Immature T Lymphoma Clones
By Miles F. Wilkinson,* Jessica Doskow,* Robert von Borstel Il,*
Alan M. Fong,$ and Carol L. MacLeod#
From the *Vollum Institute for Advanced Biomedical Research and Microbiology Department,
Oregon Health Sciences University, Portland, Oregon 97201; and the tUniversity ofCalifornia,
San Diego, Cancer Center and Department of Medicine, 14 Jolla, California 92093-0812
Summary
Cell surface proteins encoded by members ofthe immunoglobulin supergene family are sequentially
expressed during T cell ontogeny. The molecular mechanisms responsible for the regulation of
these surface molecules are not well understood. To investigate this issue, we used a series
of well characterized T lymphoma cell clones with phenotypes characteristic of distinct stages
of early thymocyte maturation. Somatic cell hybrids formed from these cell lines were employed
to detect the presence of negative regulatory molecules. The expression of CD4 and CD8 was
strongly repressed in hybrids formed between a CD4+CD8' lymphoma clone and "immature"
CD4-CD8- lymphoma clones. Individual subunits of the T cell receptor (TCR)/CD3 complex
displayed independent regulation in unique patterns in hybrid cells. Hybrids formed by fusing
CD3+ and CD3- cells completely repressed CD3-6 mRNA expression while CD3-,y, -c-, and
-1' transcripts were moderatelyinhibited or codominantly regulated. Similar to CD3-6, interleukin
2Rci(IIr2Rct), and TCR0 mRNA accumulation was trans-negatively regulated. Transcription
rate measurements demonstrated that the inhibition of CD4, CD8, CD3-.y, CD3-E, TCR0,
and 1162Rci mRNA accumulation in hybrid cells was exerted, at leastin part, at the transcriptional
level. To test whether repressional regulation is a general feature of T cells, we examined the
regulation ofsix novel genes which were selected solely on the basis of their differential expression
between two ofthe cell linesused in this study. Five of the six novel gene transcripts were repressed
in the somatic cell hybrids. Thus, inhibitor factors appear to play a general role in controlling
T cell gene expression. The model system presented here may be useful for the identification
and characterization ofrepressor molecules responsible for the regulation ofgenes expressed during
T cell ontogeny.
T
cell maturation in the thymus is characterized by the
sequential expression of several different T cell surface
proteins encoded by genes ofthe immunoglobulin supergene
family. An early event in thymocyte maturation is the tran-
sient expression of the ID2R. The expression of the I1r2R
appears to be required for subsequent maturationevents since
antibodies against IIr2R inhibit thymocyte differentiation in
vivo (1) and in organ culture in vitro (2) . The individual
members of the TCR/CD3 gene complex are also expressed
in a stage-specific manner during thymocyte maturation. The
CD3-,y, -6, and -E genes are expressed in the early phases
of thymocyte maturation, before rearrangement and expres-
sion ofTCRci and -(3 genes in human fetalthymus and liver
(3-5). Although CD3 proteins are detectable in the cytoplasm
ofimmature thymocytes early in differentiation, the proteins
are not expressed on the cell surface until all of the compo-
nents of the complex, including both TCR subunits, are
present (6, 7) . The cell surface CD4 and CD8 proteins are
expressed after IIr2R and most members of the TCR/CD3
complex during fetal ontogeny. In the adult thymus, CD4+
CD8+ (double positive) cells are the predominant thymo-
cyte population and they reside mainly in the thymic cortex
(6). During the final stages ofthymocyte maturation, a selective
shut-offof either CD4 or CD8 gene expression occurs. The
vast majority of mature thymocytes which exit the thymus
express only one of these gene products, e.g., T helper cells
express only CD4 while T suppressor/cytotoxiccells express
only CD8.
The molecular signals which regulate the genes impor-
tant in these developmental events are not well understood.
Molecular analysis is hampered by the difficulty ofobtaining
sufficient quantities ofpure thymocyte subpopulations at dis-
269
￿
J. Exp. Med. ® The Rockefeller University Press " 0022-1007/91/07/0269/12 $2.00
Volume 174 July 1991 269-280tinct stages of maturation (8). However, cloned lymphoma
cell lines have been useful in defining the regulation ofgenes
expressed in both T and B lymphoid cells (9, 10). Since the
targets of transformation are often progenitorcell types, im-
mortalizedcells are useful for studies of developmentally re-
stricted gene regulation (10, 11). Cloned tumor cell lines have
been instrumental in identifying numericallyinfrequent normal
cells at specific stages of development which would other-
wise be difficult to detect (10, 11) and for analyzing molec-
ular events which underlie differentiation processes (12).
This study focuses on a set of well characterized T lym-
phoma cell clones which correspondin phenotype to thymo-
cytes at distinct stages of maturation (13-16). The SL12 T
lymphoma cell clones were derived from a single murine cell
line (13, 14). The SL12.3 cell clone has the phenotype CD3 -
CD4 - CD8 - CD44+ (Pgp-1+) HSA+ (j11d+) Thy1+ II,
2Ra - (14, 16, 17) which is similar to the phenotype of the
most immature subset ofdouble negative thymocytes (18-21).
A second cell clone, SL12.1, is similar to the SL12.3 cell clone,
although it expresses CD3-E mRNA and class I MHC cell
surface protein (13, 16). The SL12.4 cell clone is also CD3 -
CD4 - CD8 - HSA' Thy1+, but unlike the other cell
clones, SL12.4 cells lack CD44 and express ILr2Ra (14, 15),
a phenotype characteristic of "intermediate maturity" thymo-
cytes within the double negative subset (21) that have a high
potential to differentiate into mature T cells in organ culture
or after adoptive intrathymic transfer (6, 18, 22). SL12.4 cells
accumulate CD3-y, -6, -e, and-rmRNA, and possess fully
rearranged TCR-a and-a genes (15, 16), but they do not
express TCR/CD3 on thecell surface sincethey lack or weakly
express full length TCR=a and -0 mRNAs, unless they are
suitably induced (15, 23). The SAK8 cell clone has the most
mature phenotype of the lymphoma cell lines examined in
the present study; it expresses cell surface CD4 and CD8,
and accumulates full length TCR-a and -0 transcripts, anal-
ogous to cortical thymocytes (15, 16). Somatic cell hybrids
were formed by fusing these several cell clones that represent
different maturationstages to assess the expression of develop-
mentally regulated T cell specific genes (24, 25).
These lymphoma cell clones and their hybrids were used
to test the hypothesis that T cell gene expression is repressed
by transacting factors during the early stages of thymoryte
development. Such factors may function to repress T cell
specific gene expression until the appropriate point of matu-
ration has been reached. Two lines ofevidence lead us to for-
mulate this hypothesis. First, our previous work indicates that
unstable proteins repress TCR/CD3, CD4, and CD8 gene
expression, since protein synthesis inhibitors induce or aug-
ment these transcripts in T lymphoma cell clones (15, 16,
23, 26, 27). Secondly, using somatic cell hybrids formed from
the fusion of parental cell clones which represent different
stages of thymoryte maturation, we found that TCRO and
CD3-6 mRNA accumulation is blocked by inhibitory factors
present in immature cell clones (16).
In the present study, we have extended the analysis of gene
regulation in somatic cell hybrids formed between T lym-
phomas of common origin. These hybrids were chosen be-
cause the cells have the same lineage; thus the regulation ob-
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served is likely to be relevant to T cell biology and could
involve a small set ofregulatory factors. Our analysis ofTCR0
gene expression was extended to determine whether the mech-
anism of repression is transcriptional or posttranscriptional.
To determine the generality of repressional regulation, we
have broadened the analysis to include other T cell specific
transcripts, including additional CD3 subunits, CD4, CD8,
and IIr2R. The regulation of these known genes was com-
pared with the regulation of six novel transcripts which are
differentially expressed between two of the T lymphoma cell
clones used in this study. The novel transcripts were detected
with specific cDNA clones isolated by subtraction hybrid-
ization (28). Five ofthe six cDNA clones correspond to genes
that show no significant homology to sequences present in
current databases (28). Four of the genes have been mapped
to murine chromosomes and have been given a three letter
name based upon their expression patterns. The Tea (20.5)
cDNA sequence has substantial homology with the murine
ecotropic retroviral receptor (29). Both Tea and Lov (19.5)
genes encode cell surface multiple membrane spanning pro-
teinsand both are expressed in lymphoid tissue (28, 29) . The
Tia (19.4) gene is expressed exclusively in lymphoid tissue;
both Tea and Tia gene expression are strongly induced when
splenic T cells are activated by the T cell mitogen ConA but
not by the B cell mitogen LPS. The two unnamed genes,
19.1 and 19.2, are also expressed in lymphoid tissues. The
Pem (20.2) gene encodes a highly hydrophilic protein, likely
to be intracellular (30). Unlike the other five genes, the Pem
gene is not detestably expressed in normal lymphoid tissue,
but it is expressed in a variety of immortalized and malig-
nant cells, including T lymphomas (30). The results of our
analysis of this constellation of known and novel genes indi-
cate that repressional control is a common mechanism which
regulates mRNA accumulation, and that control is exerted
at both the transcriptional and posttranscriptional level.
Materials and Methods
Cell Culture.
￿
The T lymphoma parental and hybrid cell clones
used in this study and their culture requirements have been de-
scribed (13, 14, 16). The cells were grown in DMEM containing
10% FCS and supplemented with glutamine and penicillin/strep-
tomycin. The cells were seeded so that at the time ofharvest their
cell density was between 5 x 105 and 106 cells/ml.
Immunofluorescence Staining and Flow Cytometry Analysis.
￿
Hy-
bridoma supernatants from rat fusions for the following antibodies
were provided by Dr. Robert Hyman, Salk Institute for Biological
Studies: CD8 (Lyt-2, reference 31), CD4 (L3T4, reference 32), and
Thy-1.2 (33). Cells (106) were suspended in 25 pl of buffer A (PBS
containing 10% fetal bovine serumand 0.02% sodium azide) and
the cell suspension was incubated with 2.8 IA1 ofheat treated mouse
serum for 20 min at 4°C to block potential Fc-receptors. Subse-
quently, 50,ul of rat hybridoma supernatant (diluted 1:5) was in-
cubated with the cells for 30 min at 4°C. Following three washes
in buffer A, the cells were incubated for 30 min at 4°Cwith diluted
rabbit or goat anti-rat IgG conjugated with FITC (anti-mouse
IgG activity was removed by the supplier; Zymed Laboratories Inc.,
San Francisco, CA). The negative control in all the experiments
was anti Thy 1.2 rat anti-mouse mAb. It is of the same isotype
Gene Expressionas the anti CD4 and anti CD8 used in the study. The cells were
analyzed on acytofluorograph50 Hfluorescence activated cell sorter
(Ortho Diagnostics Inc., Westwood, MA) operating with a laser
emitting at 488nm. Histograms were generatedfrom 5,000-10,000
cells analyzed usinga threedecade logarithmic amplification scale
of fluorescence emittedby single viable cells. Propidiumiodide was
used to gate out dead cells which were in all cases less than 30%
of the cells at the time of analysis. Cell viability at the beginning
of the staining procedure was >95% as assessed by trypan blue
exclusion.
DNA Probes.
￿
Themurine cDNA probes used in this studyfor
Northern analysis were a 0.6 kb CD8 (pLY2C-1) cDNA (34), a
2.1-kb CD4 (p3C) cDNA (35), a 0.75-kb CD3-y (pB10.AT3y-1)
cDNA (36), a 0.6-kb CD3-S cDNA (37), a 1.5-kb CD3-e cDNA
(38), a 1.2-kb CD3-~cDNA (39), a 0.6-kb TCR-9(86T5) cDNA
(40), a 1.3-kb 11,2R-a (mIL2R8) cDNA (41), and an epidermal
growth factor receptor (EGFR)t cDNA (42). A 1.5-kb Chinese
hamstercDNA clone, CHOA (43), which recognizes transcripts
ubiquitously expressed by all known mammalian cell types, was
used as apositive control forNorthern blots. Thefollowing novel
cDNA clones were obtained by subtraction hybridization: 19.1,
19.2, 19.4 (Tia), 19.5 (Lov), 20.2 (Pem) (28, 30), and 20.5 (Tea)
(29). For the nuclear run-off analysis, single stranded probes were
prepared by subcloning the following fragments into M13mp18
and M13mp19: the entire 0.6 kb CD8 cDNA clone, a 0.6 kb 3'
PstI/EcoR1 CD4 cDNA fragment, a 1.6 kb BamHI/Sacl Jat.3_t .7
genomic fragment, a 1.2 kb EcoRl/Clal J13z.1-z.7 genomic frag-
ment (23), a 0.5-kb 5' EcoRl/PvuII CD3-y cDNA fragment, a
0.4 kb 5' EcoRl/Xhol CD3-ecDNA fragment, 0.12-kb, and 0.5-
kb Pstl/Pstl internal CD3-(' cDNA fragments, and a 0.5-kb 5'
PstI/BamH1 muscle actin fragment. SeveralCD3-Sfragmentswere
subcloned: 61, 0.2-kb 5' EcoR1/PvuII cDNA fragment; 62, 0.3-
kb EcoR1/BamH1 IVS1 genomic fragment; 63,0.3-kbXbal/Accl
EX-IVS2 genomic fragment; 64, 0.6-kb Bg1II/PstI IVS2TM-IVS3
genomic fragment; 65, 0.3-kb Pstl/Tagl IVS3-Cl-IVS4 genomic
fragment; and 66, 0.8-kb Tagl/EcoRl IVS4-C2-3' untranslated
genomic fragment (27).
Northern Blot Analysis.
￿
Total cellular RNA was isolated from
cells as described (44). 10 Ftg of RNAwas electrophoresed(unless
otherwisenoted) in 1% agarose (formaldehyde) gels andtransferred
to S & S Nytran membranes (45). The integrity and equivalence
of RNA loaded was assessed by acridine orange staining: the gel
was stained for3minin 15 hg/mlacridine orange, 10 mM sodium
phosphate (pH 6.5) and 1.1 M formaldehyde. After destaining 20
min in the same buffer, the gel was examined on an ultraviolet
transilluminator and photographed. After transfer and UV cross-
linking, theefficiency oftransfer was assessed by staining the blot
for45 s with 0.03% methylene blue in 0.3 M sodium acetate (pH
5.2), followed by destaining in waterfor 2min. Theblot waspho-
tographed before complete removal of the stain by a 5 min wash
in lx SSPE, 1% SDS. Northern blots were hybridized with 11P-
labeled random primed cDNA fragments in the presence of 10%
dextran sulphate and 50% formamide for 12-18 h at 42°C, and
washed with O.lx SSPE, 0.1% SDS at 50-65°C (45). To remove
thelabeled probe, theRNAblots were washed at 98°C with 0.1 x
SSPE and0.1% SDS andstored at room temperature untilhybrid-
ized with the next probe. Autoradiograms were analyzed forsignal
intensity by laser densitometry. XAR film was exposed to theex-
tent that it wasin thelinear rangeoftheHelena Laboratories (Beau-
mont, TX) "Quick Scan R&D" densitometer. TheXAR5 film
1 Abbreviation used in thispaper: EGFR, epidermal growth factor receptor.
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was linear over a 50-fold range as determined by measuring the
optical absorbance of film exposed to known quantities of "P.
Southern Blot Analysis. Genomic DNA was obtained by re-
moving the DNAband from cellular lysates ultracentrifuged over
a 5.7 M cesium chloride cushion (44) followed by dialysis against
10 mM Tris (pH8), 1mM EDTA. ThegenomicDNAwasdigested
with EcoRI, followed by phenol/chloroform (1:1) extraction. The
DNA was electrophoresed in a TBE agarose gel and transferred
by vacuumblotting in alkali as described(46). Theamount ofDNA
loaded and transferred per lane was assessed by ethidium bromide
staining of the gel, and methylene blue staining of the blot (see
Northern blot analysis). Southern blots were hybridized andwashed
as described for Northern blots.
Measurement ofTranscription Rates.
￿
Nuclearrun-offexperiments
were performed to measure the rate of nascent RNA synthesized
in isolated nuclei.The nuclei from each cell line were labeled with
[a-'ZPJUTP as described (23). 3,ug of single stranded M13 DNA
containing sense and antisense sequences or 0.5 jug of double
stranded insert DNA (vectorless) were used to detect thetranscrip-
tion signal. The incorporation ranged from 0.5 to 1 cpm/nuclei.
The number of cpms hybridized was kept constant within each
eatperiment so that theresults arecomparable. Theblotswere washed
understringent conditions (23); including20-min treatmentat 37°C
with 10,ug/ml ribonuclease A and 1 ug/ml ribonuclease T1, fol-
lowed by 65°C wash in 5 mM Tris (pH 7.5), 2 mM EDTA, 10
mM NaCl and 0.4% SDS for 30 min.
Results
To investigate whether T cell gene expression is regulated
by inhibitory factors, somatic cell hybrids were formed be-
tweenparental cellswhich differ in the expression of specific
T cell gene products. The authenticity of the somatic cell
hybrids was determined by several means. The hybrids con-
tained a near-tetraploidchromosome content, ranging from
77 to 81, with an averageof 79-80for each hybrid clone (24,
25). Sincethesomaticcell hybrids are an intraspecies and in-
tralineage combination, they are unusually stable; they have
maintained their tumorigenic andkaryotypic phenotype for
several years in culture (24, 25). Southern blot analysis indi-
cates that the unique patternofTCR-O gene rearrangements
characteristic of each T lymphoma parent was also present
in the hybrid cells (16).
Repression ofCD4 and CD8 Gene Expression in Somatic Cell
Hybrids. Table 1 provides a summary of the surface pheno-
type of the SL12 and SAK8 T lymphoma clones used in the
present study(also describedin theIntroduction). Fig. 1 shows
that theSAKE T cell lymphoma clone expressed cell surface
CD4 andCD8, while theSL12.3 cell clone lacked detectable
CD4 andCD8expression. Somaticcell hybrids formed from
the fusion of SL12.3 and SAK8 cells (SL12.3 x SAK8) did
not detectably express cell surface CD8 and expressed only
negligible amounts of CD4 (Fig. 1) .
The relative amount of CD4 and CD8 mRNA was as-
sessed by Northern analysis to determine whethertherepres-
sion of cell surface protein resulted from a decrease in the
accumulation of the respective mRNAs. Fig. 2A illustrates
that SAK8 cells expressed CD4 and CD8 mRNA, whereas
neither SL12.3 cells nor thefusion product, SL12.3 x SAK8,
detectably expressed these mRNAs. Thus, the repression ofFlow cytometry was used to determine cell surface expressionsimilar to
that shown in Fig. 1. The (+) symbol denotes that the indicated cell
surface protein was expressed in the cell line listed across the top of the
table. ND s not determined. The references provide information on one
or more of the cell lines; thosemarked with an asterisk (*) are reported
for the first time in this communication.
CD4 and CD8 cell surface protein in these hybrid cellsresults
from a striking reduction in the steady state levels of CD4
and CD8 mRNA, and not from alterations in posttransla-
tional events such as protein transport, processing, or cell
surface modulation. Table 2 summarizes a quantitative den-
sitometric analysis of mRNA expression in parental and hy-
brid cells. CD4 and CD8 mRNA accumulation in SL12.3
x SAK8 hybrid cells was at least 50-fold less than in SAK8
parental cells. Similarly, the SL12.1 T lymphoma cell clone,
which is nearly identical in phenotype with SL12.3 (Table
1), engendered a strong reduction of CD4 and CD8 mRNA
expression when fused with SAK8 cells (Fig. 2 A and Table
2). The lack of CD4 and CD8 gene expression in either the
SL12.1 x SAK8 or the SL12.3 x SAK8 hybrid was not due
to the loss of, or to major alterations in the CD4 or CD8
genes. Southern blot analysis of the hybrids indicated that
the CD4 and CD8 genes were present and unaltered in size
relative to the genes present in the parental cell lines (Fig.
2 B). Although this analysis cannot rule out point mutations,
small deletions or insertions which could inactivate the pro-
tein, such subtle changes are unlikely to explain the large
differences in mRNA accumulation observed in this system.
This conclusion is further supported by the analysis of sev-
eral additional independently derived hybrid cell clones (25)
which gave completelyconcordant results (data not shown).
The preceding data support the conclusion that double nega-
tive SL12.3 and SL12.1 cellscontain transacting factors which
repress the accumulation of CD4 and CD8 mRNA. Another
double negative T lymphoma cell clone, SL12 .4, was ana-
lyzed because it has a more mature phenotype than either
SL12.1 or SL12.3 (Table 1 and introduction) and thus can
be used to determine whether transacting inhibitory factors
are a general feature of all double negative cells, regardless
of their precise maturation status. Hybrid cells formed from
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Figure 1 .
￿
Transacting factors inhibit cell surface CD4and CD8expres-
sion. The histograms show the fluorescence profile of the indicated cell
lines and somatic cell hybrids assessed by flow cytometry. The solid line
represents staining with antibodies against murine CD4or CD8as indi-
cated on the figure. The dotted line represents the fluorescence intensity
of cells stained with an antibody against Thy-1.2 (AKR mouse cells ex-
press the Thy1.1 allele).
the fusion of SAK8 and SL12.4 cells expressed CD4 and CD8
on the cell surface, albeit at reduced levels relative to SAK8
parental cells (Fig. 1). Likewise, CD4 and CD8 mRNA ex-
pression in SL12.4 x SAK8 cells was only slightly less than
parental SAK8 cells (data not shown). Thus, unlike imma-
ture SL12.1 and SL12.3 cells, SL12.4 cells do not strongly
repress CD4 and CD8 gene expression in somatic cell hybrids
formed with SAK8 cells.
The transcription rate of the CD4 and CD8 genes was
analyzed using the nuclear run-off assay to determine whether
the strong repression of CD4 and CD8 mRNA accumula-
tion in SL12.1 x SAK8 and SL12.3 x SAK8 hybrid cells
was due to transcriptional or posttranscriptional mechanisms.
Table 1 . Cell Surface
SL12 .1
Phenotype
SL12.3
of T
SL12.4
Lymphoma
SAK8
Cell Clones
Reference
CD3 - - - - (14)
CD4 - - - + (14, 24)
CD8 - - - + (13, 14)
CD44 (Pgpl) + + - - (13, 24)
CD45 (T200) + + + ND (13, 24)
IL-2r-ci - - + ND (15*)
HSA (JllD) + + + + (15)
Thyl + + + + (13, 24)
TL + + + + (14`)
H-2Kk + - - - (13, 14)Table 2.
￿
Quantitative Analysis ofmRNA Expression in Parental Cells and Somatic Cell Hybrids
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Figure 2 .
￿
Transcriptional repression
ofCD4andCD8 expression in somatic
cell hybrids. (A) Northern blots of total
cellular RNA prepared from the indi-
cated cell lines and hybrids were hybrid-
ized sequentially with purified inserts
from CD4, CD8, and Chinese hamster
(CHOA)cDNA clones . CHO-A tran-
scripts serve as an internal standard to
assess RNA amounts in each lane. (B)
Southern blots weresomewhat unevenly
loaded as assessed by staining with
ethidium bromide, and by staining the
blot with methylene blue, this accounts
for the differential intensity of the hy-
bridization in different lanes. (C) The
rate of gene transcription was assessed
by the nuclearrun-offassay using single
strandedM13 probes which recognize
sense or anti-sense nascent transcripts
as noted .
SL12.3
Relative values were determined by densitometric analysis of Northern blots . The cell line with highest expression was given the arbitrary value
of "100" . The numbers given in the table were derived by normalizing to the intensity of hybridization of a CHO-A cDNA probe as a control
for the amount ofRNA loaded in each lane . The data representing each gene is derived from one experiment . However, two or more (up to 10)
independent experiments gave completely concordant results . In cases where more than one transcript is present only the most abundant transcript
was analyzed .
SL12.3
SL12.3
X
SL12.4 SL12.4
SL12.1
X
SL12.4 SL12.1
CD4 <1 <1 <1 <1 <1
CD8 <2 <2 <2 <2 <2
CD3- .y <1 10 100 31 2.7
CD3-6 <1 <1 100 1 .8 <1
C133-e <1 6 100 16 10
CD3-~ 1.1 50 100 <1 <1
IL2r-a <2 <2 100 <2 <2
19.1 <2 17 100 8 <1
19.2 4.1 3.0 100 10 1 .5
19.4 (Tia) 3.9 4.3 100 1.1 <1
19.5 (Lov) <1 <1 100 <1 <1
20.2 (Pem) <1 32 100 42 <1
20.5 (Tea) <0.1 6 .1 100 10 <0.1
SAK8
<1
<2
1.1
SAK8
100
100
2.8
SAK8
<1
<2
1.1
<1 <1 <1
45 41 <1
30 51 <1
<2 <2 <2
1.2 2.4 13
2.7 1.8 3.7
3.6 39 2.8
<1 <1 <1
1 2.4 4.1
0.1 1 .2 <0.1We have previously shown that this assay provides a linear
signal over at least a 10-fold range of transcription rates (23) .
Fig . 2 C shows that the CD4 gene was preferentially tran-
scribed in the sense orientation in SAK8 cells, as expected,
whereas SL12.3 cells transcribed theCD4 gene at a very low
rate. The SL12.3 x SAK8 hybrid also transcribed the CD4
gene at a low rate, although higher than in SL12.3 cells (Fig.
2 C) . Similarly, SL12.1 x SAK8 hybrid cells exhibited a lower
rate of CD4 transcription than SAK8 parental cells . These
results were confirmed using 5' and 3' double-stranded CD4
DNA fragment as probes (data not shown) . Thus, a depres-
sion of the transcription rate accounts, at least in part, for
the reduced CD4 mRNA content in the hybrid cells . How-
ever, since the transcription rate o£ the CD4 gene was higher
in CD4- hybrid cells than in CD4 - SL12.1 or SL12.3 pa-
rental cells (Fig. 2 C), it appears that posttranscriptional events
also participate in the regulation ofCD4 transcript amounts .
In SAK8 cells, the CD8 gene was detectably transcribed
in the sense strand, but was not detectable in either SL12.1
x SAK8 or SL12.3 x SAK8 hybrid cells. Although this re-
sult was highly reproducible using both single stranded and
double stranded probes, the low CD8 transcription rate makes
it difficult to conclude that transcriptional repression com-
pletely accounts for the reduced CD8 mRNA expression ;
posttranscriptional events may also participate. However, lower
rates ofCD4 and CD8 gene transcription account for some
of the repressed cell surface CD4 and CD8 expression ob-
served in the hybrid cells .
TCR/CD3 Genes are Differentially Repressed by TransActing
Factor(s) .
￿
The individual transcripts encoded by the CD3
gene complex exhibit distinct patterns of expression in cell
lines (3-5, 47, 48) . We examined whether CD3 transcript
levels are regulated by repressional mechanisms, and if so,
whether the individual CD3 molecules are regulated differ-
ently. To clarify the analysis, three distinct categories of regu-
lation in somatic cell hybrids were defined : (a) the term "trans-
negative" regulation was used whenmRNA expression was
reduced in hybrid cells by greater than 20-fold, relative to
the expressing parental cell line ; (b) the term "inhibitory"
regulation was used to describe reductions of 3-20-fold in
hybrid cells; and (c) the term "codominant" regulation was
usedwhen expression was reduced less than three-fold lower
than the expressing parental cell line.
Fig. 3A and Table 2 show that SL12.4 cells expressed abun-
dant CD3-y, -S, -e, and -~ transcripts, while SL12.3 cells
expressed trace or undetectable amounts of these transcripts .
CD3-S gene expressionwas transnegatively regulated in SL12.3
x SL12.4 hybrid cells (>100-fold less than parental SL12 .4
cells) . CD3-y and -emRNA levels were inhibited 10- to 17-
fold, respectively, in SL12.3 x SL12.4 hybrid cells compared
to parental SL12.4 cells. In contrast, CD3-~ transcripts were
expressed in a codominant manner. SL12.1 x SL12.4 hybrid
cells exhibited similar regulation, except that CD3-~ expres-
sion was trans-negatively regulated (Fig. 3 and Table 2) . Since
the SAK8 clone expressed CD3-y, -e, and -~ mRNAs, we
also examined hybrids formedbetween this parent and either
SL12.1 or SL12.3 cells . SL12.3 x SAK8 cells transnegatively
regulated CD3-e and -~mRNA expression (>40-fold reduc-
tion in expression relative to parental SAK8 cells), but co-
dominantly regulated CD3-ymRNA accumulation (Fig. 3
Figure 3 .
￿
Transacting factors inhibit CD3 mRNA accumulation . Methods and additional information are described in the legend of Fig . 2 . (A)
A single Northern blot was sequentially probed with the indicated CD3 and CHO-A cDNAs. (B) Southern blot analysis . (C) Transcription rates of
the TCRS, CD3-.y, and CD3-e genes using M13 probes containing the indicatedDNA sequences which recognize sense and anti-sense nascent tran-
scripts, as noted .
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the CD3 transcripts in a codominant manner (Fig . 3 A and
Table 2) .
The repression ofCD3mRNA expression in hybrid cells
could not be explained by a lack ofCD3 genes in these cells,
as demonstrated by Southern blot analysis (Fig . 3 B) . CD3-y,
-6, -e, and -r gene copy number (relative to a fixed amount
of genomic DNA) was the same in the parental and hybrid
cell lines. The small variation in the hybridization signal which
is apparent between different cell lines (Fig. 3 B) results from
differences in the amount of genomic DNA loaded in the
lanes (see figure legend) . The additional submolar bands ob-
served in some lanes resulted from incomplete restriction diges-
tion, not new restriction sites, as shown by independent anal-
ysis in separate experiments . We conclude that transcripts
encoding the individual subunits of the CD3 complex are
differentially repressed by inhibitory factors present in SL12.1
and SL12.3 cells.
CD3 gene transcription rates were measured to determine
the mechanism by which CD3 mRNA accumulation was
repressed in somatic cell hybrids . Several single and double
stranded probes complementary to different regions ofCD3-S
and CD3-~ transcripts failed to provide a signal sufficiently
above background levels to allow assessment of transcriptional
regulation. CD3-y and -e transcriptional rates were sufficient
for analysis . CD3-e transcription rates were at least 4 fold
lower in SL12.1 x SL12.4 and SL12.3 x SL12.4 hybrid cells
as compared to SL12.4 parental cells (Fig . 3 C), consistent
with the reduced CD3-emRNA accumulation found in these
hybrid cells (Fig. 3 A and Table 2) . Transcriptional repres-
sion also accounts for the reduction in CD3-ymRNA ac-
cumulation in somatic cell hybrids . The CD3-y gene was
transcribed at a lower rate (at least threefold lower) in SL12.3
x SL12.4 hybrid cells than in SL12.4 parental cells (Fig. 3
C) consistent with the reduced CD3-ymRNA levels in this
hybrid cell line (Fig . 3 A and Table 2) .
Since TCR-(3mRNA levels are also repressed in SL12 so-
matic cell hybrids (16), we sought to determine whether the
regulation was exerted at the transcriptional or posttranscrip-
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tional level. The SL12.4 cell clone constitutively transcribes
both the Cat and Cat loci and accumulates high amounts
of 1.0-kb Cat transcripts (23) . Somatic cell hybrids formed
between a+ SL12.4 and a_ SL12.3 cells lack detectable 1.0
kb TCR-O transcripts (16) . SL12.4 cells transcribed the Cal
and Cat genes at high rates in the sense orientation, whereas
SL12.3 cells and SL12.3 x SL12.4 hybrid cells transcribed
the TCR-O gene at rates >50-fold lower (Fig . 3 C) . Simi-
larly, SL12.1 x SL12.4 hybrid cells exhibited repressed ac-
cumulation ofTCROmRNA (16) and lower transcription
rates (Fig . 3 C) . We conclude that the accumulation ofTCRf3,
CD3-y, and CD3-e transcripts are inhibited by transacting
factors present in SL12.1 and SL12.3 cells which act, at least
in part, by reducing the rate of gene transcription .
Trans-Negative Regulation ofInterleukin-2 Receptor ci Gene
Transcription in Somatic Cell Hybrids. The IL2Rot is tran-
siently expressed early during thymocyte development by a
population ofcells destined to mature into functionalT cells
(18, 22) . We examined 11,2R-a expression in somatic cell
hybrids formed between parental cells that lack detectable
expression (SL12.3 and SL12.1) and SL12.4 cells which ex-
press high levels ofIL2R-amRNA (Fig. 4A) and cell sur-
face protein (15) . IL2Rot gene expression is transnegatively
regulated in both SL12.3 x SL12.4 and SL12.1 x SL12.4
hybrid cells (Fig. 4 A and Table 2) . Southern blot analysis
revealed no detectable difference in IL2R-ci genomic struc-
ture or gene copy number in parental or hybrid cells (Fig.
4 B) . Therefore, it is likely that repressor molecules present
in SL12.1 and SL12.3 cells efficiently blocked the accumula-
tion ofIL2R-amRNA in hybrid cells formed with SL12.4.
The pattern ofIL2R-ci and CD3-S gene expression in this
system was highly similar (Table 2) . Both IL-2Ra and CD3-S
transcripts were transnegatively regulated in hybrids formed
between SL12.4 cells (IL2R-a+ CD3-S+) and either SL12.1
or SL12.3 cells (IL-2R-oz - CD3-b- ) .
IL2Ra transcription ratesshown in Fig. 4 C demonstrate
that SL12.4 cells transcribe the gene, but transcription was
repressed below measurable levels in SL12.3 x SL12.4 hy-
brid cells. In contrast, the Thyl and actin genes were tran-
Figure 4 .
￿
Transnegative regulation ofIL
2R-a gene transcription in somatic cell
hybrids . Methods and additional informa-
tion are described in the legend of Fig. 2 .
(A)A Northern blot hybridized with the
11,2R-tx cDNA probe is the same as the
blot shown in Fig . 3 . (B) . Southern blot
analysis. (C) The transcription rate was as-
sessed using double stranded insertcDNA
(IL2R-a and EGFR) or single stranded
M13DNA (actin and Thyl) which recog-
nizes sense nascent transcripts .scribed in both parental and hybrid cells, and the EGFR gene
was not detectably transcribed in any of these cells, as ex-
pected (Fig . 4 C) . Therefore, the repressed IL2R-cimRNA
accumulation in hybrid cells must result from a relatively
specific repression of IL2R-oi gene transcription.
Regulation ofSix Novel Genes in Somatic Cell Hybrids.
￿
The
preceding analysis shows that transacting factors negatively
regulate TCR, CD3, CD4, CD8, and IL2R gene expres-
sion among T cell lines which differ in maturation status.
The generality ofthis observation was tested by assessing the
regulation of novel transcripts corresponding to cDNAs
selected solely on the basis of their differential expression in
SL12.4 and SL12.3 cells. These six cDNA clones were iso-
lated by subtraction-enriched differential screening of an SL12.4
cDNA library (28, 29) . A briefsummary of the characteris-
tics of these six cDNA clones was presented in the in-
troduction .
Five of the six novel gene transcripts were expressed at
significantly lower levels in the SL12.3 x SL12.4 somatic cell
hybrid compared with the SL12.4 parent (Fig . 5 A, Table
2, and reference 28) . Three genes (19.2, Lov, and Tia) were
transnegatively regulated (>20-fold repression), while two
(19.1 and Tea) were inhibited 5-16-fold . Pem was the only
codominately expressed novel gene in SL12.3 x SL12.4 hy-
brid cells (Table 2) . The same general pattern ofgene expres-
sion was observed in SL12 .1 x SL12.4 hybrid cells (Fig . 5
A and Table 2) . The Tia gene is also expressed in SAK8 cells
and was transnegatively regulated in SL12.1 x SAK8 and
SL12.3 x SAK8 hybrid cells (Fig . 5 A and Table 2) . Tea
mRNA expression was inhibited at least 12-fold in the same
hybrid cell lines . Since none of the parental or hybrid cells
showed any detectable difference in the genes as assessed by
Southern analysis (Fig. 5 B and reference 28), the repression
ofthe genes is likely to result from transacting repressor factors
derived from the less mature SL12.1 and SL12.3 cells.
Transcription rates of the novel genes were assessed to ex-
amine whether the reduced accumulation of the novel tran-
scripts in hybrid cells was regulated at the transcriptional or
posttranscriptional level . Fig . 5 C shows that five of the six
novel genes were transcribed at detectable rates in SL12.4 cells
(i.e., at rates greater than EGFR, which is not transcribed
in T cells) . The transcription rate of the Lov gene was too
low to detect . The transcription rates of the 19.1, 19.2, Tia,
and Tea genes were only moderately repressed (threefold or
less) in hybrid cells compared with SL12.4 parental cells (Fig.
5 C) . For comparison, TCR-/3 and CD3-e gene transcrip-
tion rates were assessed in the same experiment; the tran-
scription rate of TCR-f3 gene was dramatically reduced in
hybrid cells and CD3-e gene transcription was moderately
repressed in hybrid cells, while actin and Thy1 gene tran-
scription was similar in all cell lines (Fig. 5 C) . The data in-
dicate that the depressed accumulation o£ 19.1, 19.2, Tia, and
TeamRNA in hybrid cells (Table 2) resulted from the com-
bined effects of a slight decrease in transcription and a major
posttranscriptional regulatory component . Pem gene transcrip-
tion was similar in parental and hybrid cells (Fig. 5 C) con-
sistent with the codominant regulation of Pem transcripts
(Table 2 and reference 28) .
Thus, repressional mechanisms prevent the accumulation
of a wide variety of developmentally regulated transcripts in
Figure 5 .
￿
Several novel T cell genes are regulated by negative transacting factors . Methods and additional information are described in the legend
of Fig. 2 . (A) The Northern blot was hybridized sequentially with the purified inserts Tia, Tea, and CHO-A cDNA . (B) Southern blot analysis . (C)
The transcription rate was assessed using purified double stranded DNA inserts (the novel genes) or single stranded M13 DNA (TCR-(3, CD3-e,
actin, and Thyl) which recognizes sense nascent transcripts . The data shown for Pem was derived from the experiment shown in Fig . 4 C . The data
shown for 19 .1 and 19 .2 was from a shorter autoradiographic exposure, as compared with the data shown for the other genes.
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accumulation of the mRNAs using different strategies, by
regulating both transcriptional and postranscriptional events.
Discussion
The data presented in this communication show that nega-
tive.factors, present in somatic cell hybrids, regulate T cell
specific gene expression. Repression was exerted on transcripts
encoding cell surface molecules of known function (TCR,
CD3, CD4, CD8, and IlT2R), as well as on several novel
transcripts. The inhibition was mediated by factors present
in immature SL12.1 and SL12.3 T lymphoma clones. Since
our analysis involved fusion of cells from the same cell lin-
eage and in many cases, from the same cell line source, it
is unlikely that the results can be explained by phenotypic
extinction, which occurs when somatic cell hybrids are formed
between cells of different lineages. For example, immuno-
globulin gene expression in myeloma cells is extinguished
when these cells are fused with fibroblasts or T cells (49-51),
and Thyl expression is repressed when Thy-1 " T cells are
fused with Thy1- B cells (52) . Phenotypic extinction is im-
portant since the molecules involved may participate in main-
taining lineage fidelity. In contrast, since we examined hybrids
formed between cells of the same lineage, the regulation ex-
erted may be more relevant to maturational control within
a lineage. The SL12.1 and SL12.3 cell clones are not gener-
ally repressiveto the T cell phenotype since they express many
"early" T cell gene products such as Thyl, CD44, CD45,
heat shock antigen, and Thymic leukemia (Table 1).
The coregulation of CD4 and CD8 gene transcription in
somatic cell hybrids may be relevant to the coexpression of
these two genes in the majority of adult thymocytes. A
common repressive mechanism which operates on both CD4
and CD8 expression may be relieved when double negative
thymocytesundergo conversion to the double positive pheno-
type. Consistent with this interpretation is our observation
that CD4 and CD8 transcripts are coordinately induced in
SL12.4 cell clones in response to treatment with protein syn-
thesis inhibitors or coculture with thymic epithelial cells (15).
Our results from somatic cell hybrids also define two types
of CD4- CD8 cells: those with an "immature" phenotype
(SL12.1 and SL12.3) which strongly repress C134 and CD8
gene transcription and cellswith an "intermediate maturity"
phenotype (SL12.4) that only weakly inhibit CD4 and CD8
gene expression. The apparent coordinate regulation of CD4
and CD8 gene regulation is intriguing, but further work is
required to determine whether the same repressor molecule(s)
control the expression of these genes. Mechanisms which in-
dependently regulate CD4 and CD8 expression must also
exist since CD8 is activated before CD4 in at least some im-
mature thymocytes, and most mature thymocytes selectively
inactivate either CD4 or CD8 expression before their release
from the thymus (6) .
Individual members ofthe CD3 complex are independently
regulated in our intralineage somatic cell hybrids. CD3-6
mRNA levels were strongly repressed (>50-fold) by trans-
acting factors present in SL12.1 and SL12.3 cells. In contrast,
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CD3--y, -e, and-r mRNAs were inhibited to a lesser extent,
and in unique patterns in different hybrid cells. Studies ex-
amining thymocytesand leukemia cells provide some evidence
for selective expression of particular TCR/CD3 subunits at
different stages ofmaturation: (a) cell clones of human origin
which lack cell surface CD3 selectively express CD3-e mRNA,
but not -y or -6 mRNA, suggesting that these latter tran-
scripts may accumulate somewhat later in maturation (47);
(b) CD3-6 transcripts are not evident in mouse fetal thymo-
cytes until day 16 of gestation, when full length TCRß tran-
scripts are already expressed (53); and (c) neither CD3-6 nor
-e mRNAs are detestably expressed by marine Thyl +
CD44+ thymocyte clones obtained from day 14 embryos
which accumulate CD3-y transcripts, and possess TCR-a,
-ß, and -y genes in a germ line conformation (48). A common
feature of these examples ofasynchronous expression ofCD3
subunits from human and marine T cells is that the CD3-6
gene is expressed laterin ontogeny than the other CD3 genes.
This is consistent with our observation that the accumula-
tion of CD3-6 transcripts is more dramatically inhibited by
transacting factors than the other CD3 transcripts. The CD3-6
protein is known to prevent the degradation of partial
TCR/CD3 complexes in the endoplasmic reticulum by neu-
tralizing the charged amino acids present in the transmem-
brane spanning domain of the TCR-ct subunit (54). Thus,
the unique regulation of CD3-6 may play a role in control-
ling the subcellular fate of TCR/CD3 complexes during on-
togeny.
IL-2R-(x gene transcription is understrong repressional con-
trol in somatic cell hybrids. The regulation of IL2R-ct and
CD3-6 gene expression was identical in the cell lines and so-
matic cell hybrids examined. IL2R-ci and CD3-6 transcripts
were not expressed by double negative cell clones (CD4-
CD8 - ) with an immature phenotype (SL12.1 and SL12.3)
but were expressed by an intermediate maturity double nega-
tive cell clone (SL12.4). The expression of both transcripts
was strongly transnegatively regulated (>50-fold) in hybrids
formed between the immature and intermediate maturity cell
clones. This pattern of regulation is consistent with the ob-
servation that neither of these genes is expressed in the most
immature double negative thymocyte subsets, but both are
expressed before CD4 and CD8 expression (11, 53). Whether
the coordinate regulation of IL2Ra and CD3-6is coincidental
or not, independent regulatory mechanisms must also exist
since cell surface IL2R is only transiently expressed during
early thymocyte maturation, while CD3-6 mRNA remains
constitutively expressed throughout the remaining phases of
development. An interesting feature of IL-2R gene regula-
tion is its biphasic expression during T cell maturation.
IL2R-ci is first expressed early in immature thymocytes, fol-
lowed by shut-off during laterphases of ontogeny, and reex-
pression in mature antigen-activated T cells. It remains for
future investigations to determine whether a common repres-
sive mechanism operates to inhibit IL2R expression during
these distinct IL2R - phases of maturation.
Our data support the hypothesis that repressional control
is a common mode ofregulating the expression of T cell tran-
scripts which encode surface molecules of known function.In addition, the expression of several novel transcripts was
inhibited by repressor factors in hybrid cells. All five of the
novel transcripts whose accumulation was repressed in so-
matic cell hybrids are expressed in normal lymphoid tissue.
The only gene not repressed in somatic cell hybrids, Pem,
is unique among the novel genes in that it is not detectably
expressed in any normal adult tissues, including lymphoid
organs (30) . The Pem gene is expressed in a variety of im-
mortalized and transformed cell lines from several cell lineages.
Thus, the expression of Pem in T lymphoma cell clones is
more likely to reflect their tumorigenic status than their lin-
eage. Hence, it is not surprising that the Pem gene is regu-
lated in a different manner than genes expressed by normal
lymphoid cells.
The variable degree of inhibition exerted on different T
cell transcripts in somatic cell hybrids could result from a
single inhibitory factor which acts with variable efficiency.
However, it seemsmore likely that multiple inhibitory factors
are involved since there are both quantitative and qualitative
differences in the expression of several of the transcripts ex-
amined. Many of the genes had unique patterns of expres-
sion in the panel of somatic cell hybrids. Furthermore, the
mechanism by which transcript accumulation was inhibited
was primarily transcriptional for some of the MRNAs, while
for others, the predominant mode of regulation was post-
transcriptional.
A growing body ofliterature supports the notion that lym-
phoid genes are regulated by repressor factors. Three main
lines of investigation support this view. First, the induction
or augmentation of specific lymphoid transcripts aftertreat-
ment with protein synthesis inhibitors has suggested the im-
portant role of labile inhibitor polypeptides. Immunoglob-
ulin K transcripts are induced by cycloheximide treatment (55),
perhaps due to selective removal of the inhibitor I-u B, which
controls the activity of the NF-rc B transcription factor (56).
We have shown that the expression of full length TCR-tx
and -R transcripts in SL12 clones is dramatically induced by
transcriptional and posttranscriptional mechanisms in response
to different agents, including protein synthesis inhibitors (16,
23, 26). Second, studies with somatic cell hybrids have indi-
cated that immunoglobulin, class I MHC, TCR, Thyl, and
CD44 genes are repressed by transacting factors (16, 49-52,
57-60). Third, molecular studies have identifiedcis- and trans-
acting factors which negatively regulate the expression ofsev-
eral lymphoid genes, including immunoglobulin, TCR, 11,2,
IIr2Rci and c-myc (49, 50, 56, 61-65) . Studies analyzing
extinction of immunoglobulin expression in inter-lineage
hybrids has revealed that negative regulation is exerted on
the is promoter and heavy chain enhancer (50), perhaps acting
on the conserved octamer sequence which controls immu-
noglobulin gene expression (49). Silencer elements have been
identified in the 3' flanking regions of the TCRct and --y
genes; these silencers may promote fidelity of TCR expres-
sion in cxo- and -yb-bearing T cells, respectively (64, 65). Puta-
tive repressor factors have been characterized which regulate
immunoglobulin heavy chain (62) and c-myc (63) gene tran-
scription.
The T lymphoma hybrids used in this study have several
unique features useful for identifying and characterizing nega-
tive regulators which control the expression of T cell genes.
The hybrids were formed from parents of common origin
and lineage which couldlimit the number ofrepressor mole-
cules under investigation. The large number of T cell tran-
scripts regulated in the somatic cell hybrids permits a com-
parative analysis of regulation within a single model system.
The orchestration of inhibitory factors may be analogous in
some respects to positive transcriptional regulation as it is
currently understood (66). An emerging model proposes that
a limited number of positive transcription factors activates
the expression of a wide array of genes by acting in concert
in an overlapping manner (66) . By analogy, negative regula-
tion couldbe exerted by a small number of repressor factors
which use combinatorial diversity to act on a single gene or
on a set of different genes to regulate their expression. The
analysis of negative regulation requires biological systems
which are suitably accessible to molecular scrutiny.
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